Undecylenic Acid Therapy in Psoriasis and Neurodermatitis (Atopic Dermatitis)
نویسندگان
چکیده
منابع مشابه
Psoriasis and Atopic Dermatitis
Psoriasis and atopic dermatitis are common, chronic inflammatory skin diseases. We discuss several aspects of these disorders, including: risk factors; incidence and prevalence; the complex disease burden; and the comorbidities that increase the clinical significance of each disorder. We also focus on treatment management strategies and outline why individualized, patient-centered treatment reg...
متن کاملCoexistence of psoriasis and atopic dermatitis
Psoriasis is a recurrent inflammatory skin disease which affects around 2% of the population and is characterized by erythematous papules and plaques covered with silvery white scales. [1]. Atopic dermatitis (AD) is a common skin condition, particularly in children, regarded as one of the 50 most prevalent diseases worldwide [2]. Prevalence of AD in adult patients is around 1-3 % [3]. Patients ...
متن کاملOcclusive Therapy in Atopic Dermatitis
Misha M. Heller1, Eric S. Lee2, Faranak Kamangar3, Wilson Liao4 and John Y. M. Koo4 1University of Southern California, Keck School of Medicine, Los Angeles, California 2University of Nebraska Medical Center, College of Medicine, Omaha, Nebraska 3University of California Davis, School of Medicine, Sacramento, California 4University of California San Francisco, Department of Dermatology San Fran...
متن کاملTWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
Atopic dermatitis (AD) and psoriasis are driven by alternate type 2 and type 17 immune responses, but some proteins might be critical to both diseases. Here we show that a deficiency of the TNF superfamily molecule TWEAK (TNFSF12) in mice results in defective maintenance of AD-specific T helper type 2 (Th2) and psoriasis-specific Th17 cells in the skin, and impaired expression of disease-charac...
متن کاملAdalimumab in Recalcitrant Severe Psoriasis Associated with Atopic Dermatitis
Tumor necrosis factor-α inhibitors may induce various cutaneous side effects including eczematous-like lesions. The management of such side effects can be challenging. Herein, we report a case of a 55-year-old man who had a flare-up and subsequent improvement of atopic dermatitis during treatment of severe psoriasis with adalimumab.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Investigative Dermatology
سال: 1950
ISSN: 0022-202X
DOI: 10.1038/jid.1950.39